BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21988933)

  • 1. Hemoglobin mass and biological passport for the detection of autologous blood doping.
    Pottgiesser T; Echteler T; Sottas PE; Umhau M; Schumacher YO
    Med Sci Sports Exerc; 2012 May; 44(5):835-43. PubMed ID: 21988933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
    Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
    Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers.
    Mørkeberg J; Sharpe K; Belhage B; Damsgaard R; Schmidt W; Prommer N; Gore CJ; Ashenden MJ
    Scand J Med Sci Sports; 2011 Apr; 21(2):235-43. PubMed ID: 19903320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-transfusion stability of haemoglobin mass.
    Pottgiesser T; Specker W; Umhau M; Roecker K; Schumacher YO
    Vox Sang; 2009 Feb; 96(2):119-27. PubMed ID: 19152604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total hemoglobin mass--a new parameter to detect blood doping?
    Prommer N; Sottas PE; Schoch C; Schumacher YO; Schmidt W
    Med Sci Sports Exerc; 2008 Dec; 40(12):2112-8. PubMed ID: 18981937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hb mass measurement suitable to screen for illicit autologous blood transfusions.
    Pottgiesser T; Umhau M; Ahlgrim C; Ruthardt S; Roecker K; Schumacher YO
    Med Sci Sports Exerc; 2007 Oct; 39(10):1748-56. PubMed ID: 17909402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for autologous blood transfusions.
    Mørkeberg J; Belhage B; Ashenden M; Bornø A; Sharpe K; Dziegiel MH; Damsgaard R
    Int J Sports Med; 2009 Apr; 30(4):285-92. PubMed ID: 19199200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of hemoglobin mass estimation with the optimized CO-rebreathing method on different spectrophotometers.
    Ulrich G; Strunz J; Frese F; Bärtsch P; Friedmann-Bette B
    Scand J Med Sci Sports; 2012 Apr; 22(2):224-31. PubMed ID: 21210851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the trail of blood doping-microRNA fingerprints to monitor autologous blood transfusions in vivo.
    Mussack V; Wittmann G; Pfaffl MW
    Am J Hematol; 2021 Mar; 96(3):338-353. PubMed ID: 33326140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current strategic approaches for the detection of blood doping practices.
    Segura J; Ventura R; Pascual JA
    Forensic Sci Int; 2011 Dec; 213(1-3):42-8. PubMed ID: 21889274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control technique to reduce the variability of longitudinal measurement of hemoglobin mass.
    Gough CE; Sharpe K; Ashenden MJ; Anson JM; Saunders PU; Garvican LA; Bonetti DL; Gore CJ; Prommer N
    Scand J Med Sci Sports; 2011 Dec; 21(6):e365-71. PubMed ID: 21535184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of low-volume blood withdrawal on hematological biomarkers for the athlete biological passport.
    Krumm B; Saugy JJ; Botrè F; Faiss R
    Drug Test Anal; 2024 Feb; 16(2):168-173. PubMed ID: 37303297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulocyte and haemoglobin profiles in elite triathletes over four consecutive seasons.
    Díaz V; Lombardi G; Ricci C; Jacobs RA; Montalvo Z; Lundby C; Banfi G
    Int J Lab Hematol; 2011 Dec; 33(6):638-44. PubMed ID: 21707935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.